MOTS-c 10mg

Mitochondrial Peptide

MOTS-c 10mg

Advanced cellular energy and metabolic optimization

MOTS-c is a mitochondrial-derived peptide that enhances cellular energy production, improves metabolic function, and supports healthy aging by optimizing mitochondrial efficiency. This naturally occurring peptide regulates glucose metabolism, promotes fat oxidation, and enhances exercise performance by activating critical metabolic pathways at the cellular level.

10mg

Therapeutic Dose

SC/IM

Administration

3-7x

Weekly Dosing

4-12

Week Protocols

Most Popular

10mg Vial

Standard therapeutic dosage

3-7 injections per week

Subcutaneous or IM

4-12 week cycles

Ideal For

Individuals seeking enhanced metabolic function, improved exercise performance, increased cellular energy, optimized glucose metabolism, fat loss support, and healthy aging through mitochondrial optimization.

Get Started

The Science

What is MOTS-c?

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a recently discovered mitochondrial-derived peptide that plays a crucial role in cellular energy metabolism and metabolic homeostasis. This 16-amino acid peptide is encoded within the mitochondrial genome and represents a novel class of signaling molecules that communicate between mitochondria and the nucleus to regulate whole-body metabolism.

MOTS-c functions as a powerful metabolic regulator by activating AMPK (AMP-activated protein kinase), a master metabolic switch that enhances glucose uptake, promotes fat oxidation, and improves insulin sensitivity. By optimizing mitochondrial function, MOTS-c increases cellular energy production (ATP), reduces oxidative stress, and supports metabolic flexibility—the ability to efficiently switch between burning carbohydrates and fats for fuel.

Research demonstrates that MOTS-c levels decline with age, contributing to age-related metabolic dysfunction and decreased cellular energy. Supplementation with MOTS-c has shown remarkable potential for improving exercise performance, enhancing recovery, supporting healthy weight management, regulating blood sugar levels, and promoting longevity by restoring youthful mitochondrial function. This makes MOTS-c particularly valuable for individuals seeking to optimize metabolic health, enhance athletic performance, support healthy aging, or address metabolic concerns such as insulin resistance and metabolic syndrome.

Book a Consultation

AMPK Activation

Activates AMPK signaling to enhance glucose uptake, promote fat oxidation, and improve cellular energy metabolism, acting as a metabolic master switch for optimal energy balance.

Metabolic Regulation

Improves insulin sensitivity and glucose metabolism while promoting metabolic flexibility, enabling efficient fuel utilization and supporting healthy blood sugar regulation.

Mitochondrial Function

Enhances mitochondrial efficiency and ATP production while reducing oxidative stress, supporting cellular energy generation and protecting against age-related mitochondrial decline.

Learn If You Qualify

Enhanced Cellular Energy

Optimizes mitochondrial ATP production for increased cellular energy, reducing fatigue and enhancing overall vitality and physical performance capacity.

Improved Exercise Performance

Enhances endurance, strength, and recovery by optimizing energy metabolism and reducing exercise-induced fatigue for superior athletic performance and training adaptations.

Metabolic Optimization

Improves insulin sensitivity, glucose metabolism, and metabolic flexibility, supporting healthy blood sugar regulation and efficient nutrient utilization.

Fat Loss & Body Composition

Promotes fat oxidation and healthy weight management by enhancing metabolic rate and improving the body’s ability to utilize fat as fuel.

Healthy Aging Support

Counteracts age-related metabolic decline by restoring mitochondrial function, supporting longevity, and promoting cellular health throughout the aging process.

Cardio-Metabolic Health

Supports cardiovascular function and metabolic health by improving vascular function, reducing oxidative stress, and enhancing overall cardio-metabolic resilience.

Start Your Journey

Initial Assessment

Comprehensive metabolic evaluation including health history, fitness goals, and current metabolic function to determine candidacy.

Diagnostic Testing

Complete metabolic panel, glucose tolerance assessment, and baseline labs to establish your metabolic profile and track improvements.

Customized Protocol

Receive personalized MOTS-c dosing regimen tailored to your metabolic goals, activity level, and therapeutic objectives.

Ongoing Monitoring

Regular follow-ups with metabolic testing, performance tracking, and protocol optimization to maximize results and ensure safety.

Book Your Consultation

Safety & Candidacy

Is MOTS-c Right for You?

MOTS-c is a naturally occurring mitochondrial peptide with an excellent safety profile. Our medical team performs comprehensive metabolic assessments to ensure appropriate candidacy and optimal dosing for your individual needs.

• Bioidentical Peptide — MOTS-c is identical to the naturally occurring peptide produced by your mitochondria, ensuring excellent biocompatibility.
• Well-Tolerated — Clinical research demonstrates excellent tolerability with minimal adverse effects across diverse populations.
• Non-Hormonal — Works through metabolic signaling pathways without disrupting hormonal balance or requiring PCT protocols.
• Medical Supervision — All therapy is physician-directed with regular metabolic monitoring and dose optimization for safety and efficacy.

Speak With a Physician

100%

Naturally occurring mitochondrial peptide bioidentical to human MOTS-c

10+

Years of research validating safety and metabolic benefits

MOTS-c is a mitochondrial-derived peptide that regulates cellular energy metabolism by activating AMPK, a master metabolic switch. It enhances glucose uptake, promotes fat oxidation, improves insulin sensitivity, and optimizes mitochondrial function for increased cellular energy production. MOTS-c acts as a signaling molecule that communicates between mitochondria and the nucleus to regulate whole-body metabolism, supporting metabolic health, exercise performance, and healthy aging.

MOTS-c provides comprehensive metabolic benefits including enhanced cellular energy and reduced fatigue, improved exercise performance and endurance, better insulin sensitivity and glucose metabolism, support for healthy weight management and fat loss, increased metabolic flexibility, enhanced recovery from exercise, and protection against age-related metabolic decline. Many users also report improved mental clarity, sustained energy throughout the day, and better overall vitality. Clinical research supports its role in optimizing metabolic health and promoting longevity.

MOTS-c is administered via subcutaneous or intramuscular injection, typically 3-7 times per week depending on individual goals and response. The standard therapeutic dose is 10mg per injection, though dosing is personalized based on your metabolic profile, activity level, and treatment objectives. Most protocols run for 4-12 weeks, with some individuals benefiting from ongoing use or periodic cycles. Your BHRC physician will determine the optimal dosing schedule and duration for your specific needs.

Many individuals notice increased energy and improved exercise performance within the first 1-2 weeks of consistent use. Metabolic improvements such as enhanced insulin sensitivity and better glucose regulation typically become apparent within 2-4 weeks. More significant changes in body composition, endurance, and metabolic markers generally develop over 4-8 weeks of therapy. For optimal results in metabolic optimization and longevity support, protocols of 8-12 weeks are recommended, with benefits often sustained beyond the treatment period.

MOTS-c has an excellent safety profile with minimal reported side effects. Occasional mild injection site reactions may occur. Unlike anabolic compounds, MOTS-c does not affect hormonal balance and does not require post-cycle therapy. However, individuals with active metabolic disorders, certain chronic conditions, or those taking medications for diabetes should consult with their physician before starting therapy. Comprehensive medical evaluation and baseline metabolic testing ensure safe and appropriate use. There are no known significant drug interactions, but full medication disclosure is essential during consultation.

Yes, MOTS-c can be safely combined with other peptide therapies, hormone optimization, nutritional interventions, and exercise programs. Many patients stack MOTS-c with NAD+ for enhanced cellular energy and longevity benefits, with CJC-1295/Ipamorelin for body composition optimization, or as part of comprehensive metabolic health protocols. It’s also compatible with conventional medications and supplements, though your BHRC physician will review all current treatments to design an integrated protocol optimized for your metabolic goals and health objectives.

MOTS-c therapy is typically not covered by insurance as it’s considered preventive and regenerative medicine focused on metabolic optimization and longevity. BHRC offers transparent pricing and flexible payment options to make this innovative metabolic therapy accessible. Many patients find the investment worthwhile given the comprehensive benefits for energy, performance, metabolic health, and healthy aging. Our team can provide detailed cost information and discuss payment plans during your consultation.

Get Started Today

Get Started

Begin Your Transformation

Schedule a consultation with our medical team to learn if MOTS-c peptide therapy is right for your wellness journey.

"*" indicates required fields

Or call us directly: +1 213-325-3373

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. MOTS-c is provided for metabolic optimization and wellness purposes under physician supervision. Individual results may vary. A consultation with our medical team and baseline laboratory testing are required to determine if this therapy is appropriate for you.

MOTS-c at BHRC: At a Glance

AdministeredSubcutaneous injection

Typical frequency2–3 times per week

Typical cycle8–12 weeks, then reassess

OnsetMost report changes from weeks 3–6

Baseline labsMetabolic panel, HbA1c, fasting insulin

SupervisionPrescribed and monitored by a BHRC provider

What a MOTS-c Protocol Actually Involves

MOTS-c is a mitochondrial-derived peptide studied for its role in cellular energy metabolism and insulin sensitivity. At BHRC it is not sold as a standalone product you self-administer without oversight — it is prescribed as part of a monitored protocol built around your baseline labs and goals.

1. Consultation and history reviewA provider reviews your metabolic history, current medications, training load, sleep and prior peptide or hormone use. This determines whether MOTS-c is appropriate at all, and whether another approach would serve you better.
2. Baseline laboratory workTypically a comprehensive metabolic panel, HbA1c, fasting insulin and lipid panel. Body composition may be measured. These numbers become the benchmark you are measured against later — without them, ‘is it working?’ is guesswork.
3. Protocol designYour provider sets the starting dose, frequency and cycle length based on your labs and objectives, generally starting conservatively and titrating. Timing relative to training and fasting is set here as well.
4. Dispensing and administration trainingYou are shown reconstitution, syringe measurement, injection-site rotation and storage. Patients who inject correctly and consistently get materially better results than those who improvise.
5. Follow-up and reassessmentLabs and subjective markers are re-checked partway through the cycle. Dose is adjusted, held or discontinued based on what actually changed — not on how long you have been on it.

The structure matters more than the molecule. Most disappointing peptide outcomes trace back to no baseline labs, inconsistent administration, or an unrealistic timeline rather than to the peptide itself. For the full technical breakdown — dosing ranges, reconstitution math, syringe calculations and cycle structures — see our complete MOTS-c dosage guide.

Book a MOTS-c Consultation

What to Expect, Week by Week

Response varies between individuals, and the timeline below reflects what patients on a supervised protocol commonly report rather than a guaranteed outcome. Your provider will set expectations specific to your labs, history and goals.

Note: MOTS-c is not a weight-loss drug and should not be selected on that basis. It is studied primarily for mitochondrial and metabolic function. Patients seeking substantial weight reduction are usually better served by a different approach, which your provider will discuss with you.

How MOTS-c Compares to Other Options

MOTS-c occupies a specific niche. It is frequently confused with growth-hormone secretagogues and with GLP-1 medications, which do very different things. This comparison is intended to help you arrive at your consultation with better questions.

These are not mutually exclusive, and combinations are common — but stacking multiplies both cost and risk, and should only be done under supervision with a clear rationale for each addition.

Who Is and Isn’t a Candidate

Often appropriate for

• Adults with declining energy or exercise tolerance that is not explained by an untreated underlying condition
• Patients with early metabolic markers — elevated fasting insulin or rising HbA1c — who are already engaged in diet and training
• Active adults focused on recovery capacity and healthy aging
• Patients who have completed baseline lab work and are willing to be monitored through a full cycle
• Patients who understand this is an adjunct to training, nutrition and sleep, not a replacement for them

Not appropriate for

• Anyone pregnant, breastfeeding or actively trying to conceive
• Patients with an active malignancy or a recent cancer history, unless specifically cleared by their oncologist
• Patients with uncontrolled diabetes or unstable cardiovascular disease, until those conditions are managed
• Competitive athletes subject to WADA or USADA testing — peptide use carries sanction risk and must be checked against current prohibited lists
• Anyone unwilling to complete baseline and follow-up laboratory work
• Minors, and anyone seeking to self-administer without provider oversight

Candidacy is decided in consultation, not online. BHRC providers review your history, current medications and baseline labs before any peptide protocol is prescribed. MOTS-c is dispensed only under provider supervision.

Monitoring and Follow-Up

Monitoring is the part patients most often want to skip and the part that most determines whether a protocol was worth doing. A peptide cycle without measurement produces an anecdote, not a result.

• Metabolic panel and fasting insulin — the most direct read on whether the metabolic rationale is holding up
• HbA1c — slower to move, but meaningful across a full cycle
• Lipid panel — tracked alongside the metabolic picture
• Body composition — where applicable, measured consistently rather than by scale weight alone
• Functional markers — training performance, recovery time, sleep quality and daytime energy, tracked by you and reviewed at follow-up
• Tolerability — injection-site reactions, GI symptoms or anything unexpected, reported as it happens rather than at the next visit

If mid-cycle markers have not moved and you feel no functional difference, the appropriate response is to stop and reassess rather than extend the cycle or raise the dose. Your provider will make that call with you.

MOTS-c Questions, Answered

Do I need a prescription for MOTS-c?

Yes. At BHRC, MOTS-c is prescribed and dispensed under provider supervision following a consultation and baseline labs. We do not sell it as an unsupervised product. Peptides marketed online as ‘research use only’ sit outside that framework and carry real sourcing, purity and legal risk.

How much does MOTS-c therapy cost at BHRC?

Cost depends on your protocol — dose, cycle length, whether MOTS-c is used alone or alongside other therapies, and what lab work is required. Pricing is reviewed transparently during your consultation before anything is prescribed. Peptide therapy is generally not covered by insurance.

Where can I get MOTS-c near me?

BHRC provides physician-supervised peptide therapy across its locations, including West Hollywood, West Los Angeles, Valencia, Paradise Valley and Summerlin. Consultations determine candidacy and protocol; ongoing monitoring is handled through your treating location.

Is MOTS-c FDA-approved?

MOTS-c is not an FDA-approved drug. It is available through compounding pharmacies and used off-label under provider supervision. Research in humans remains limited relative to established medications, which is precisely why supervision, baseline labs and follow-up monitoring matter.

How is MOTS-c different from a GLP-1 like semaglutide or tirzepatide?

They are not comparable therapies. GLP-1 medications are studied and prescribed primarily for clinically significant weight reduction and glycemic control. MOTS-c is studied for mitochondrial and metabolic function — energy, exercise capacity and insulin sensitivity. If substantial weight loss is your goal, a GLP-1 is far more likely to be the appropriate conversation.

How long before I notice anything?

Most patients who report changes describe them beginning somewhere between weeks three and six, usually as steadier energy or improved recovery rather than anything dramatic. Objective laboratory changes are assessed at mid-cycle. Anyone promising results in the first fortnight is overselling.

Can MOTS-c be combined with other peptides?

Yes, and it commonly is — frequently alongside growth-hormone secretagogues or NAD+ protocols. Every addition compounds both cost and risk, so each element should have a specific rationale. Stacking decisions are made in consultation, not assembled from forum protocols.

What are the side effects?

The most commonly reported are injection-site reactions — redness, tenderness or mild swelling — which usually resolve with proper site rotation and technique. Some patients report transient fatigue or GI discomfort early in a cycle. Anything persistent, severe or unexpected should be reported to your provider promptly.

Will MOTS-c make me fail a drug test?

Potentially, yes. Peptides are subject to WADA and USADA prohibited lists, and status can change. If you compete in a tested sport, verify current status against the governing list before starting any peptide protocol. Do not rely on general guidance for this — the consequences fall on the athlete.

What happens at the end of a cycle?

A washout period is standard practice. Follow-up labs and functional markers are reviewed against your baseline, and that determines whether a further cycle is justified, whether the protocol should change, or whether MOTS-c was simply not the right tool for your goals.

Speak With a BHRC Provider

Selected Research

The literature below is peer-reviewed background on MOTS-c and the mechanisms discussed on this page. It is provided so you can read the primary sources yourself. It is not evidence of any particular outcome at BHRC, and much of it is preclinical — animal or cell-culture work that has not been replicated in humans. Your provider will discuss what the evidence does and does not support for your situation.

1. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab (2015). PubMed 25738459
2. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress. Cell Metab (2018). PubMed 29983246
3. MOTS-c modulates skeletal muscle function by directly binding and activating CK2. iScience (2024). PubMed 39559755
4. MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation. Front Endocrinol (Lausanne) (2023). PubMed 36761202
5. Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases. Diabetes Metab J (2023). PubMed 36824008
6. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med (2026). PubMed 41966639